戻る
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541.HK)価格
01541.HK 株価推移チャート
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$0
0%
$0
レギュラーマーケット： Jan 28, 16:02:56 HKT
データなしFollow-Up Questions
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.の主要な財務諸表は何ですか？
01541.HKの主要な財務比率は何ですか？
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.の収益はセグメントまたは地域別にどのように分けられていますか？
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.は収益を上げていますか？
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.に負債はありますか？
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.の発行済株式数は何株ですか？
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
2.3M
1株当たり利益(TTM)
-0.93
配当利回り
--
時価総額
--
IMMUNEONCO-Bとは何ですか？
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.